Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: Involvement of NF-κB signaling activation in CD4+ T cells

Toxicology and Applied Pharmacology

Volumn 269, Issue 3, 2013, Pages 270-279

  Shu, Guangwen ^a   Yang, Tianming ^a   Wang, Chaoyuan ^a   Su, Hanwen ^b   Xiang, Meixian ^a  

^a SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Antitumor; CD4+ T cells; Gastrodin; Immunomodulation; NF B

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GASTRODIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; NATURAL PRODUCT; PARISHIN B; PROTEIN BCL 2; UNCLASSIFIED DRUG; VANILLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TRANSPLANTATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG PURIFICATION; ENZYME ACTIVATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; LIVER CELL; LIVER CELL CARCINOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZYL ALCOHOLS; CD4-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GLUCOSIDES; IMMUNITY, CELLULAR; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; NEOPLASM TRANSPLANTATION; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA; GASTRODIA ELATA; MUS;

EID: 84877003443     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.02.019     Document Type: Article

References (42)

1. Armeanu S., Krusch M., Baltz K.M., Weiss T.S., Smirnow I., Steinle A., Lauer U.M., Bitzer M., Salih H.R. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma. Clin. Cancer Res. 2008, 14:3520-3528.
2. Avella D.M., Li G., Schell T.D., Liu D., Zhang S.S., Lou X., Berg A., Kimchi E.T., Tagaram H.R., Yang Q., Shereef S., Garcia L.S., Kester M., Isom H.C., Rountree C.B., Staveley-O'Carroll K.F. Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model. Hepatology 2012, 55:141-152.
3. Baldwin A.S. Regulation of cell death and autophagy by IKK and NF-kappaB: critical mechanisms in immune function and cancer. Immunol. Rev. 2012, 246:327-345.
4. Biswas K., Richmond A., Rayman P., Biswas S., Thornton M., Sa G., Das T., Zhang R., Chahlavi A., Tannenbaum C.S., Novick A., Bukowski R., Finke J.H. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction. Cancer Res. 2006, 66:6816-6825.
5. Cayir K., Karadeniz A., Simsek N., Yildirim S., Karakus E., Kara A., Akkoyun H.T., Sengul E. Pomegranate seed extract attenuates chemotherapy-induced acute nephrotoxicity and hepatotoxicity in rats. J. Med. Food 2011, 14:1254-1262.
6. Chen X., Nie W., Yu G., Li Y., Hu Y., Lu J., Jin L. Antitumor and immunomodulatory activity of polysaccharides from Sargassum fusiforme. Food Chem. Toxicol. 2012, 50:695-700.
7. Cui G., Florholmen J. Polarization of cytokine profile from Th1 into Th2 along colorectal adenoma-carcinoma sequence: implications for the biotherapeutic target?. Inflamm. Allergy Drug Targets 2008, 7:94-97.
8. Dong G.H., Wang J., Zhang Y.H., Liu M.M., Wang D., Zheng L., Jin Y.H. Induction of p53-mediated apoptosis in splenocytes and thymocytes of C57BL/6 mice exposed to perfluorooctane sulfonate (PFOS). Toxicol. Appl. Pharmacol. 2012, 264:292-299.
9. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
10. Finke J., Ferrone S., Frey A., Mufson A., Ochoa A. Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol. Today 1999, 20:158-160.
11. Gerondakis S., Grumont R., Rourke I., Grossmann M. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. Curr. Opin. Immunol. 1998, 10:353-359.
12. Grimm M., Gasser M., Bueter M., Strehl J., Wang J., Nichiporuk E., Meyer D., Germer C.T., Waaga-Gasser A.M., Thalheimer A. Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases. BMC Cancer 2010, 10:82.
13. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
14. Hoechst B., Voigtlaender T., Ormandy L., Gamrekelashvili J., Zhao F., Wedemeyer H., Lehner F., Manns M.P., Greten T.F., Korangy F. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009, 50:799-807.
15. Hung K., Hayashi R., Lafond-Walker A., Lowenstein C., Pardoll D., Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J. Exp. Med. 1998, 188:2357-2368.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-Delta Delta CT Method. Methods 2001, 25:402-408.
17. Llambi F., Green D.R. Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr. Opin. Genet. Dev. 2011, 21:12-20.
18. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
19. Ma H., Zhang Y., Wang Q., Li Y., He J., Wang H., Sun J., Pan K., Chen M., Xia J. Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation. Cancer Biol. Ther. 2010, 9:903-907.
20. Marrack P., Kappler J. Control of T cell viability. Annu. Rev. Immunol. 2004, 22:765-787.
21. Marsden V.S., Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 2003, 21:71-105.
22. Ormandy L.A., Farber A., Cantz T., Petrykowska S., Wedemeyer H., Horning M., Lehner F., Manns M.P., Korangy F., Greten T.F. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J. Gastroenterol. 2006, 12:3275-3282.
23. Pardee A.D., Butterfield L.H. Immunotherapy of hepatocellular carcinoma: unique challenges and clinical opportunities. Oncoimmunology 2012, 1:48-55.
24. Park S., Kim da S., Kang S. Gastrodia elata Blume water extracts improve insulin resistance by decreasing body fat in diet-induced obese rats: vanillin and 4-hydroxybenzaldehyde are the bioactive candidates. Eur. J. Nutr. 2011, 50:107-118.
25. Perez-Diez A., Joncker N.T., Choi K., Chan W.F., Anderson C.C., Lantz O., Matzinger P. CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 2007, 109:5346-5354.
26. Rakhra K., Bachireddy P., Zabuawala T., Zeiser R., Xu L., Kopelman A., Fan A.C., Yang Q., Braunstein L., Crosby E., Ryeom S., Felsher D.W. CD4+ T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation. Cancer Cell 2010, 18:485-498.
27. Shi Y., Feng Y., Kang J., Liu C., Li Z., Li D., Cao W., Qiu J., Guo Z., Bi E., Zang L., Lu C., Zhang J.Z., Pei G. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat. Immunol. 2007, 8:817-824.
28. Shu G., Tang Y., Zhou Y., Wang C., Song J.G. Zac1 is a histone acetylation-regulated NF-kappaB suppressor that mediates histone deacetylase inhibitor-induced apoptosis. Cell Death Differ. 2011, 18:1825-1835.
29. Stockinger B., Kassiotis G., Bourgeois C. Homeostasis and T cell regulation. Curr. Opin. Immunol. 2004, 16:775-779.
30. Strasser A., Pellegrini M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 2004, 25:610-615.
31. Taylor R.C., Cullen S.P., Martin S.J. Apoptosis: controlled demolition at the cellular level. Nat. Rev. Mol. Cell Biol. 2008, 9:231-241.
32. Teitz-Tennenbaum S., Li Q., Davis M.A., Chang A.E. Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model. Clin. Immunol. 2008, 129:482-491.
33. Tong Y.Q., Liu B., Zheng H.Y., He Y.J., Gu J., Li F., Li Y. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma. PLoS One 2011, 6:e27804.
34. van Malenstein H., Gevaert O., Libbrecht L., Daemen A., Allemeersch J., Nevens F., Van Cutsem E., Cassiman D., De Moor B., Verslype C., van Pelt J. A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma. Clin. Cancer Res. 2010, 16:4278-4288.
35. Vasievich E.A., Huang L. The suppressive tumor microenvironment: a challenge in cancer immunotherapy. Mol. Pharm. 2011, 8:635-641.
36. Verslype C., Libbrecht L. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults. Best Pract. Res. Clin. Gastroenterol. 2007, 21:983-996.
37. Weil R., Israel A. T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes. Curr. Opin. Immunol. 2004, 16:374-381.
38. Xiao R., Tian Y., Liu L., Xu K. Action of silky chicken-Gastrodia elata Blume nutrient solution on immunoregulatory function in mice. Wei Sheng Yan Jiu 2009, 38:283-286.
39. Zhang K.H., Tian H.Y., Gao X., Lei W.W., Hu Y., Wang D.M., Pan X.C., Yu M.L., Xu G.J., Zhao F.K., Song J.G. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res. 2009, 69:5340-5348.
40. Zhang Y., Yu G., Wang D., Hu Y., Lei W. ERK1/2 activation plays important roles in the opposite effects of Trichostatin A in non-cancer and cancer cells. Toxicon 2011, 57:932-937.
41. Zhang C.L., Zeng T., Zhao X.L., Yu L.H., Zhu Z.P., Xie K.Q. Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats. Int. J. Biol. Sci. 2012, 8:363-374.
42. Zhao X., Shu G., Chen L., Mi X., Mei Z., Deng X. A flavonoid component from Docynia delavayi Franch. Schneid represses transplanted H22 hepatoma growth and exhibits low toxic effect on tumor-bearing mice. Food Chem. Toxicol. 2012, 50:3166-3173.